Ebreichsdorf, Austria

Rudolf Hauptmann

USPTO Granted Patents = 24 


 

Average Co-Inventor Count = 5.3

ph-index = 10

Forward Citations = 307(Granted Patents)


Location History:

  • Vienna, AT (1997)
  • Ebreichsdorf, DE (1997)
  • A2483 Ebreichsdorf, AT (2002)
  • Ebreichdorf, AT (2009)
  • Ebreichsdorf, AT (1990 - 2012)

Company Filing History:


Years Active: 1990-2012

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: Rudolf Hauptmann: A Pioneer in Pharmaceutical Innovations

Introduction

Rudolf Hauptmann, based in Ebreichsdorf, Austria, is a distinguished inventor with a remarkable portfolio of 24 patents. His innovative research primarily focuses on pharmaceutical compositions and methods that aim to improve treatment outcomes in various medical fields.

Latest Patents

Among Rudolf Hauptmann's latest inventions are significant advancements in the use of pyridodihydropyrazinones. This patent discloses these compounds, detailing processes for their preparation and potential applications as pharmaceutical compositions. The compounds follow a specific general formula, allowing for flexibility in their application in medicinal chemistry.

Additionally, Hauptmann has contributed to the therapeutic landscape with his patent concerning the use of Lck inhibitors for treating immunologic diseases. This invention outlines a method for addressing pathological conditions involving an immunologic component using Lck inhibitors, which are known as kinase inhibitors in oncology. The approach emphasizes their use in conjunction with other drugs, thereby broadening the therapeutic options available for managing such diseases.

Career Highlights

Rudolf's expertise is evident in his collaboration with notable companies in the pharmaceutical sector, including Boehringer Ingelheim International GmbH and Amgen Inc. His tenure in these prestigious organizations underscores his impact on drug development and innovation.

Collaborations

Hauptmann has worked closely with esteemed colleagues in the field, including Ingrid Maurer-Fogy and Christian Stratowa. Together, they have pursued research that bridges various aspects of pharmaceutical science, enhancing the efficacy of treatments available to patients.

Conclusion

Rudolf Hauptmann is a key figure in the landscape of pharmaceutical innovations, evidenced by his numerous patents and collaborations. His work on pyridodihydropyrazinones and Lck inhibitors represents significant contributions to the field, aiming to improve the quality of life for individuals suffering from immunologic diseases. As he continues his research, the impact of his inventions is sure to resonate in the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…